Pentixapharm Holding AG · ISIN: DE000A40AEG0 · Directors Dealings
Insider Transaction Snapshot

Pentixapharm Holding AG

Directors Dealings: 4th October 2024
Reporting obligation triggered by: Eckert Wagniskapital und Frühphasenfinanzierung GmbH
Trading volume: 33.643.068,00 EUR
Type: not specified

The Insider Transaction was made by Eckert Wagniskapital und Frühphasenfinanzierung GmbH . The transaction toke place on 3rd October 2024. The order was executed at the trading place Frankfurter Wertpapierbörse. The aggregated volume was 33.643.068,00 EUR, based on an average price of 5,10 EUR. The nature of the Investment was not specified.

Short Selling Radar - Net Short Selling Positions

EQS-Newswire - Latest Company News, Ad-hoc News, Research

Directors Dealings

Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.

Reset filter
New DD.i/o
11 November 2022
CompuGroup Medical SE & Co. KGaA: A reportable insider transaction was published on 11th November 2022. The reporting obligation was triggered by a person related to Closely associated.

Transaction reporting date: 11th November 2022,

The Insider Transaction was made by GT 1 Vermögensverwaltung GmbH . The transaction toke place on 10th November 2022. The order was executed at the trading place Xetra. . The aggregated volume was 319.725,00 EUR, based on an average price of 35,00 EUR. The nature of the Investment was Buy.

CompuGroup Medical SE & Co. KGaA
04 November 2022
CompuGroup Medical SE & Co. KGaA: A reportable insider transaction was published on 4th November 2022. The reporting obligation was triggered by a person related to Closely associated.

Transaction reporting date: 4th November 2022,

The Insider Transaction was made by GT 1 Vermögensverwaltung GmbH . The transaction toke place on 3rd November 2022. The order was executed at the trading place Xetra. . The aggregated volume was 231.212,56 EUR, based on an average price of 32,00 EUR. The nature of the Investment was Buy.

CompuGroup Medical SE & Co. KGaA
05 July 2022
CompuGroup Medical SE & Co. KGaA: A reportable insider transaction was published on 4th July 2022. The reporting obligation was triggered by a person related to Closely associated.

Transaction reporting date: 4th July 2022,

The Insider Transaction was made by GT 1 Vermögensverwaltung GmbH . The transaction toke place on 4th July 2022. The order was executed at the trading place Xetra. . The aggregated volume was 98.400,00 EUR, based on an average price of 41,00 EUR. The nature of the Investment was Buy.

CompuGroup Medical SE & Co. KGaA
22 June 2022
CompuGroup Medical SE & Co. KGaA: A reportable insider transaction was published on 20th June 2022. The reporting obligation was triggered by a person related to Closely associated.

Transaction reporting date: 20th June 2022,

The Insider Transaction was made by GT 1 Vermögensverwaltung GmbH . The transaction toke place on 17th June 2022. The order was executed at the trading place Xetra. . The aggregated volume was 75.962,80 EUR, based on an average price of 37,98 EUR. The nature of the Investment was Buy.

CompuGroup Medical SE & Co. KGaA
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

Important note:
The information presented here is usually updated once a day. Insofar as you include insider information/director dealings in your daily investment decisions and time-critical parameters play a role in the implementation of your trading strategy, you can obtain this information via a corresponding query at the BaFin or by monitoring the EQS-News intraday publications. 


Further information on the topic can be found on the following pages:

https://www.bafin.de/EN/Aufsicht/BoersenMaerkte/Transparenz/InformationspflichtenEmittenten/DirectorsDealings/directorsdealings_node.html https://www.bafin.de/DE/PublikationenDaten/Jahresbericht/Jahresbericht2016/Kapitel5/Kapitel5_2/Kapitel5_2_4/kapitel5_2_4_node.html https://www.bafin.de/DE/Aufsicht/BoersenMaerkte/Marktmissbrauch/Insiderueberwachung/insiderueberwachung_node.html https://www.bafin.de/DE/PublikationenDaten/Jahresbericht/Jahresbericht2017/Kapitel5/Kapitel5_2/Kapitel5_2_4/kapitel5_2_4_node.html https://www.bafin.de/DE/PublikationenDaten/Datenbanken/DirectorsDealings/directorsdealings_node.html